)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Kromek Group
Kromek Group (KMK) investor relations material
Kromek Group H2 2026 (Q&A) earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2026 (Q&A) earnings summary21 Sep, 2026
Executive summary
Revenue for FY 2027 is expected to be GBP 30.3 million, in line with market consensus from two brokers.
Midterm revenue target is GBP 60 million by 2030/2031, with continued growth anticipated beyond that period.
Growth is driven by both Advanced Imaging (notably SPECT and CT) and CBRN segments, with new customer ramp-up and geographic expansion.
The Siemens enablement agreement has transformed the financial outlook, validated IP, and strengthened OEM relationships.
Financial highlights
FY 2027 revenue guidance is GBP 30.3 million, with Advanced Imaging and CBRN both contributing to growth.
High-margin licensing revenue declined from GBP 16.5 million to GBP 10 million year-over-year to April 2026, impacting EBIT and return on capital employed.
Underlying business margins are being maintained or improved, with tight control on overheads.
Cash at April 2026 was GBP 4.2 million, with GBP 5.7 million debt; GBP 2 million of debt repaid shortly after year-end.
Outlook and guidance
Confident in delivering FY 2027 revenue of GBP 30.3 million.
Midterm target of GBP 60 million revenue and 30% EBITDA margin by 2030/2031, with further growth expected.
EBITDA margin expected to be maintained as revenue grows.
Free cash flow is not expected to be positive in FY 2027 due to increased working capital needs in Advanced Imaging.
Sufficient working capital facilities are in place to support growth without further shareholder dilution.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Kromek Group
- Strong revenue growth and profit, with robust outlook across advanced imaging, CBRN, and biosecurity.KMK
H2 2026 Pre-Recorded - FY26 revenues and PBT in line with expectations, with strong growth in both core divisions.KMKH2 2026 TU
- Profitability and margin growth achieved as revenue hit £15.0m, targeting £60m and 30% EBITDA.KMKH1 2026
- Siemens deal, rising margins, and strong contracts underpin profitable growth and ambitious targets.KMKH2 2025
- FY25 brings >30% revenue growth, first positive PBT, and ambitious midterm financial targets.KMKCMD Q&A 2025
- FY25 marks a shift to profitability and >30% revenue growth, targeting >£60M revenue midterm.KMKCMD 2025
- Record revenue, positive EBITDA, and strong contract wins drive confident growth outlook.KMKH2 2024
- FY 2025 revenue and profit to exceed expectations, underpinned by strategic partnerships.KMKTrading Update
- Siemens Healthineers deal and margin gains set the stage for profitability in FY 2025.KMKH1 2025
Next Kromek Group earnings date
H1 202719 Jan, 2027
Kromek Group
Next Kromek Group earnings date
H1 202719 Jan, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Kromek Group plc is an international technology group specializing in the development, manufacture, and marketing of radiation detection solutions. The company's core technology is based on Cadmium Zinc Telluride (CZT), a semiconductor material that allows for high-resolution radiation detection. Kromek's products find applications across a diverse set of markets including medical imaging, civil nuclear, security screening, and homeland security. Their product portfolio is designed to enhance safety and security by enabling the detection of radiological and biological threats, as well as improving medical diagnostics through advanced imaging technologies. Kromek's offerings include hardware and software components for radiation detectors and comprehensive detection systems. These systems are used in various applications ranging from environmental monitoring and power plant safety to medical diagnostics and security. The company is headquartered in Sedgefield, England, and its shares are listed on the London Stock Exchange.